Connect Biopharma Holdings Ltd (CNTB) stock
CNTBNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.58−0.06 (-9.98%)
Close on Nov 17, 2026Market cap $36.45MP/E –Yield –
Connect Biopharma operating margin
Operating margin is operating income as a percentage of revenue.
Connect Biopharma's operating margin for the twelve months ending Jun 30, 2026 was -2384.5%. For fiscal 2025 it was -90740.6%, against -86.2% the year before.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -90740.6% | −90654.4 |
| FY2024 | Dec 31, 2024 | -86.2% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -636.0% | +742.1 |
| Q1 FY2026 | Mar 31, 2026 | -11601.8% | −10465.9 |
| Q3 FY2025 | Sep 30, 2025 | -110481.3% | −110537.8 |
| Q2 FY2025 | Jun 30, 2025 | -27966.7% | – |
| Q4 FY2024 | Dec 31, 2024 | -1378.1% | – |
| Q3 FY2024 | Sep 30, 2024 | -1135.8% | – |
| Q2 FY2024 | Jun 30, 2024 | 56.6% | – |
See a number that looks wrong?